Suppr超能文献

一项关于昂丹司琼、托烷司琼或格拉司琼预防全身麻醉患者术后恶心呕吐的随机双盲研究

[A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia].

作者信息

Quan Xiang, Ye Tie-Hu, Zhu Bo

机构信息

Department of Anesthesiology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Feb;29(1):107-10.

Abstract

OBJECTIVE

To compare the efficacy of different 5-hydroxytryptamine 3 receptor antagonists in the prevention of postoperative nausea and vomiting (PONV) in patients undergoing general anesthesia.

METHODS

Totally 360 patients, American Society of Anesthesiologists (ASA) grade I - II, aged 18-75 years, and having received elective operation with endotracheal intubation general anesthesia, were randomly divided into three double-blind groups: ondansetron group, tropisetron group, and granisetron group, with 120 patients in each group. Before anesthesia induction, patients were intravenously given ondansetron (4 mg), tropisetron (5 mg), or granisetron (3 mg), respectively. The episodes of nausea and vomiting were recorded for 24 hours after operation.

RESULTS

No significant differences were observed in the terms of complete inhibition rate of PONV among ondansetron group (70.0%), tropisetron group (68.6%), and granisetron group (72.9%) within 24 hours postoperatively (P >0.05), and so did postoperative nausea incidences (22.5%, 25.4%, and 20.3%, respectively), and postoperative vomiting incidences (10.0%, 13.6%, and 8.5%, respectively) (P > 0.05). No remarked antiemetic-related adverse effects were observed within 24 hours postoperatively.

CONCLUSION

Intravenous ondansetron (4 mg), tropisetron (5 mg), or granisetron (3 mg) before anesthesia induction can prevent PONV with similar efficacy and safety.

摘要

目的

比较不同5-羟色胺3受体拮抗剂预防全身麻醉患者术后恶心呕吐(PONV)的疗效。

方法

选取360例美国麻醉医师协会(ASA)分级为I-II级、年龄在18至75岁之间、接受择期气管插管全身麻醉手术的患者,随机分为三个双盲组:昂丹司琼组、托烷司琼组和格拉司琼组,每组120例。麻醉诱导前,分别给患者静脉注射昂丹司琼(4毫克)、托烷司琼(5毫克)或格拉司琼(3毫克)。记录术后24小时内恶心呕吐的发作情况。

结果

术后24小时内,昂丹司琼组(70.0%)、托烷司琼组(68.6%)和格拉司琼组(72.9%)的PONV完全抑制率差异无统计学意义(P>0.05),术后恶心发生率(分别为22.5%、25.4%和20.3%)和术后呕吐发生率(分别为10.0%、13.6%和8.5%)差异也无统计学意义(P>0.05)。术后24小时内未观察到明显的与止吐相关的不良反应。

结论

麻醉诱导前静脉注射昂丹司琼(4毫克)、托烷司琼(5毫克)或格拉司琼(3毫克)预防PONV的疗效和安全性相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验